Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
Trial ID or NCT#
The aim of this postmarket study is to compare the safety and effectiveness of the Altis Single Sling (SIS) to an FDA cleared transobturator and/or retropubic sling through 36 months.
A Post-Market Evaluation of the Altis® Single Incision Sling System Versus Transobturator or Retropubic Mesh Sling in the Treatment of Female Stress Urinary Incontinence
- - The subject is female and at least 18 years of age. - The subject is able and willing to complete all procedures and follow-up visits indicated in this protocol. - The subject has confirmed stress urinary incontinence through cough stress test or urodynamics. - The subject has failed two non-invasive incontinence therapies (such as Kegal exercise, behavior modification, pad use, biofeedback, etc.) for > 6 months.
- - The subject has an active urogenital infection or active skin infection in region of surgery. - The subject has confirmed Pelvic Organ Prolapse (POP) of Stage 2 or higher as determined by POP-Q prolapse grading. - The subject is having a concomitant pelvic floor procedure. - The subject has incontinence due to neurological causes (e.g. multiple sclerosis, spinal cord/brain injury, cerebrovascular accident, detrusor-external sphincter dyssynergia, Parkinsons disease, or similar conditions). - The subject had a prior surgical stress urinary incontinence treatment. - The subject has undergone radiation or brachy therapy to treat pelvic cancer. - The subject has urge predominant incontinence by MESA assessment. - The subject has an atonic bladder or post void residual (PVR) above 100 cc on ≥ 2 occasions. - The subject is pregnant and/or is planning to get pregnant in the future. - The subject has a contraindication to the surgical procedure of the product Instructions for use (IFU). - The subject is enrolled in a concurrent clinical trial of any treatment (drug or device) that could affect continence function, without the sponsors approval.
Contact us to find out if this trial is right for you.